Publications by the researcher in collaboration with Alfredo Adán Civera (24)

2024

  1. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration

    Frontiers in Immunology, Vol. 15

  2. Posner-Schlossman Syndrome European Study Group: study protocol and baseline patients characteristics of a multicentre study

    British Journal of Ophthalmology

2023

  1. Clinical Features and Outcomes of Tubulointerstitial Nephritis and Uveitis Syndrome in Spain and Portugal: The IBERTINU Project

    Ocular Immunology and Inflammation, Vol. 31, Núm. 2, pp. 286-291

  2. Herpetic Anterior Uveitis Multicentre Longitudinal Study (The UVHER Project). Baseline Characteristics

    Ocular Immunology and Inflammation, Vol. 31, Núm. 7, pp. 1497-1504

  3. Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study

    Clinical and experimental rheumatology, Vol. 41, Núm. 10, pp. 2105-2114

  4. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

  5. The retinal bacillary layer detachment: Clinical features and outcomes in posterior uveitis

    Journal Francais d'Ophtalmologie, Vol. 46, Núm. 8, pp. 916-920

2022

  1. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature

    Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475

  2. Guía de recomendaciones para el manejo de brolucizumab

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 11, pp. 626-638

  3. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2021

  1. Impacto de la infección por el nuevo coronavirus en los pacientes con uveítis asociada a una enfermedad autoinmune: resultado de la encuesta COVID-19-GEAS pacientes

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 7, pp. 347-352

  2. Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group

    Revista Clinica Espanola, Vol. 221, Núm. 4, pp. 221-225

2020

  1. Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy

    Ocular Immunology and Inflammation, pp. 1-8

  2. Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group

    Ophthalmology

  3. Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

    Frontiers in Immunology, Vol. 11

  4. Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach

    European Journal of Ophthalmology, Vol. 30, Núm. 5, pp. 1042-1052

2019

  1. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

2018

  1. Endoftalmitis traumática

    Traumatología ocular

2016

  1. Safety and efficacy of intravitreal dexamethasone implants in the management of macular edema secondary to infectious uveitis

    Retina, Vol. 36, Núm. 9, pp. 1778-1785

2015

  1. Uveitic macular oedema after treatment with vemurafenib

    Acta Ophthalmologica